• OPEN AN ACCOUNT
Indian Indices
Sensex
82,031.81 -500.38
( -0.61%)
Global Indices
Nasdaq
50,652.56 -976.61
(-1.89%)
Dow Jones
7,328.13 -109.46
(-1.47%)
Hang Seng
59,089.01 228.58
(0.39%)
Nikkei 225
10,545.68 -144.19
(-1.35%)
Forex
USD-INR
93.96 -0.30
(-0.32%)
EUR-INR
103.45 -0.43
(-0.42%)
GBP-INR
123.99 -0.51
(-0.41%)
JPY-INR
0.59 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
97.3802066
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
128.53
448687.64
EPS(TTM)
Face Value()
Div & Yield %
14.55
1
0.86
 

Timken India consolidated net profit rises 29.17% in the September 2026 quarter
Oct 30,2026
Net profit of Timken India rose 29.17% to Rs 120.90 crore in the quarter ended September 2026 as against Rs 93.60 crore during the previous quarter ended September 2025. Sales rose 25.39% to Rs 986.04 crore in the quarter ended September 2026 as against Rs 786.35 crore during the previous quarter ended September 2025.

ParticularsQuarter Ended
Sep. 2026Sep. 2025% Var.
Sales986.04786.35 25
OPM %18.6818.17 -
PBDT191.79152.94 25
PBT162.87126.27 29
NP120.9093.60 29